Abstract
Transfusions are regularly employed in the care of the critically ill. While the transmission of infectious agents and clerical errors have long been major concerns, a more common non-infectious complication of transfusion, namely acute lung injury/acute respiratory distress syndrome (ALI/ARDS), has been neglected. Indeed, during the past several years, post-transfusion ALI/ARDS (transfusion-related acute lung injury — TRALI) has become the leading cause of transfusion-related death in the United States [1]. It likely occurs much more frequently than previously estimated. With skyrocketing health care costs and the continuous emphasis on improvement in patient care, it is of paramount importance to better define this transfusion-related phenomenon and to design effective strategies for its prevention. Several investigator groups have been on the leading edge in the quest to clearly elucidate this disease entity and define its prevalence.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Toy P, Popovsky MA, Abraham E, et al (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33:721–726
Popovsky MA, Moore SB (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25:573–577
Kleinman S, Caulfield T, Chan P, et al (2004) Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44:1774–1789
Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA (2002) Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA 287:1968–1971
Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ (1982) Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144:124–130
Hudson LD, Milberg JA, Anardi D, Maunder RJ (1995) Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293–301
Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC (2004) Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 125:203–211
Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC (2005) Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33:1191–1198
Gajic O, Dara SI, Mendez JL, et al (2004) Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med 32:1817–1824
Gajic O, Rana R, Mendez JL, et al (2004) Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion 44:1468–1474
Holness L, Knippen MA, Simmons L, Lachenbruch PA (2004) Fatalities caused by TRALI. Transfus Med Rev 18:184–188
Croce MA, Tolley EA, Claridge JA, Fabian TC (2005) Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 59:19–23
Hebert PC, Wells G, Blajchman MA, et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417
Silliman CC, Voelkel NF, Allard JD, et al (1998) Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 101:1458–1467
Seeger W, Schneider U, Kreusler B, et al (1990) Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 76:1438–1444
Sachs UJ, Hattar K, Weissmann N, et al (2005) Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood: Oct 6 (Epub ahead of print)
Silliman CC, Ambruso DR, Boshkov LK (2004) Transfusion-related acute lung Injury (TRALI). Blood 2266–2273
Palfi M, Berg S, Ernerudh J, Berlin G (2001) A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 41:317–322
Insunza A, Romon I, Gonzalez-Ponte M, et al (2004) Implementation of a strategy to prevent TRALI in a regional blood centre. Transfus Med 14:157–164
Bray RA, Harris SB, Josephson CD, Hillyer CD, Gebel HM (2004) Unappreciated risk factors for transplant patients: HLA antibodies in blood components. Hum Immunol 65:240–244
Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al (2003) Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101:454–462
Reiter CD, Wang X, Tanus-Santos JE, et al (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8:1383–1389
Bernard GR, Artigas A, Brigham KL, et al (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
Gajic O, Moore SB (2005) Transfusion-related acute lung injury. Majo Clin Proc 80:766–770
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science + Business Media Inc.
About this paper
Cite this paper
Belsher, J., Khan, H., Gajic, O. (2006). Transfusion as a Risk Factor for ALI and ARDS. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/0-387-35096-9_27
Download citation
DOI: https://doi.org/10.1007/0-387-35096-9_27
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-30156-3
Online ISBN: 978-0-387-35096-7
eBook Packages: MedicineMedicine (R0)